GlassScriptPhysician profile
Henry Lawrence Gardiner
NPI 1346275658
$876.18
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $150 · 2021: $286 · 2022: $302.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $155.13 | 2020-2022 | |
| Abbvie INC. | $140.25 | 2021-2022 | |
| Amarin Pharma, INC. | $102.40 | 2021-2022 | |
| Novo Nordisk INC | $74.69 | 2019-2020 | |
| Amgen INC. | $70.89 | 2019-2021 | |
| Clarus Therapeutics INC. | $31.09 | 2021 | |
| Pfizer INC. | $31.09 | 2019-2021 | |
| Avanos Medical | $29.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.66 | 2022 | |
| Lilly USA, LLC | $27.08 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.64 | 2022 | |
| Astellas Pharma US INC | $17.09 | 2019 | |
| Dermira, INC. | $15.78 | 2020 | |
| Therapeuticsmd, INC. | $14.56 | 2019 | |
| Merck Sharp & Dohme LLC | $14.11 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.90 | 2021 | |
| Horizon Therapeutics Plc | $13.78 | 2019 | |
| Esperion Therapeutics, INC. | $13.72 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.58 | 2021 | |
| Upsher-Smith Laboratories LLC | $13.32 | 2020 | |
| Allergan, INC. | $13.30 | 2020 | |
| Currax Pharmaceuticals LLC | $11.39 | 2021 | |
| Optos, INC. | $11.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Gardiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.